Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
28 studies found for:    Open Studies | "Telangiectasis"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † Effect of Avastin in Juxtafoveal Telangiectasias
Condition: Telangiectasis
Interventions: Drug: Bevacizumab;   Procedure: Intravitreal injection of Bevacizumab
2 Recruiting Laser Therapy Versus Electrosurgery For Nasal Telangiectasias
Condition: Telangiectasis
Interventions: Device: Pulsed Dye Laser;   Device: Long Pulsed Alexandrite Laser;   Device: Pulsed Dye Laser Plus Nd:YAG Laser;   Procedure: Electrodesiccation
3 Unknown † Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia Patients
Condition: Ataxia Telangiectasia
Interventions: Biological: Prevenar® (7-valent pneumococcal conjugate vaccine);   Biological: Pneumovax® (pneumococcal polysaccharide vaccine)
4 Unknown † Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
Conditions: Ataxia Telangiectasia;   Growth Failure
Intervention: Drug: Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate
5 Not yet recruiting Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
Condition: Telangiectasia, Hereditary Hemorrhagic
Interventions: Drug: Pazopanib;   Drug: Placebo
6 Recruiting Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
Condition: Hereditary Hemorrhagic Telangiectasia
Intervention:
7 Recruiting Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
Condition: Hereditary Hemorrhagic Telangiectasia (HHT).
Interventions: Drug: Topical timolol maleate;   Drug: placebo saline drops
8 Unknown † Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Intervention: Drug: Thalidomide
9 Unknown † Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Submucosal Bevacizumab
10 Recruiting QOL Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye Laser
Conditions: Breast Cancer;   Radiation-Induced Telangiectasias
Intervention: Behavioral: questionnaires
11 Unknown † Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness
Conditions: Telangiectasis;   Erythema
Interventions: Device: Pulsed dye laser;   Device: Intense pulsed light
12 Unknown † Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families
Condition: Telangiectasia, Hereditary Hemorrhagic
Intervention:
13 Not yet recruiting Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia
Condition: Ataxia-Telangiectasia (A-T)
Interventions: Other: with gene correction;   Other: without gene correction
14 Unknown † Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia
Condition: Telangiectasia, Hereditary Hemorrhagic
Intervention:
15 Recruiting Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose
Condition: Telangiectasia, Hereditary Hemorrhagic
Intervention: Drug: bevacuzimab spray
16 Recruiting Iron Deficiency and Hereditary Haemorrhagic Telangiectasia
Condition: Hereditary Haemorrhagic Telangiectasia
Intervention: Drug: Ferrous sulphate 200mg oral tablet
17 Recruiting Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Interventions: Drug: Bevacizumab;   Drug: placebo
18 Not yet recruiting Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
Conditions: Hereditary Hemorrhagic Telangiectasia;   Idiopathic Vascular Ectasia
Intervention: Drug: Pomalidomide
19 Unknown † Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Bevacizumab
20 Recruiting Oxidative Stress, Low Grade Inflammation, Tissue Breakdown and Biomarkers in Cerebrospinal Fluid of A-T
Condition: Ataxia Telangiectasia
Intervention: Procedure: Lumbar puncture
To Top

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
† Indicates status has not been verified in more than two years